Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Idexx Laboratories (IDXX)

IDEXX Laboratories director Asha Collins resigns; board reduced from ten to nine

Neutral Impact 2 of 5 leadership Written later

IDEXX Laboratories disclosed that director Dr. Asha Collins resigned from its Board of Directors effective immediately on February 13, 2025. The company said the resignation was not due to any disagreement over its operations, policies or practices, and it reduced the board size from ten to nine directors.

Key points

  • Dr. Asha Collins resigned from the Board effective immediately on February 13, 2025
  • The filing states the resignation was not due to any disagreement with the company on operations, policies or practices
  • Board size reduced from ten to nine directors

The filing

CompanyIdexx Laboratories (IDXX)
Form8-K, current report
Filed with the SECFeb 14, 2025, 4:00 PM ET
Accession number0000874716-25-000011

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 14, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.